U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07503405) titled 'Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge Model' on March 25.

Brief Summary: This will be a randomized, double-blind, placebo-controlled proof of concept study to evaluate the prophylactic efficacy and safety of orally administered TRX-100 in healthy adults challenged with influenza A/France/759/2021 (H1N1) virus.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Influenza

Intervention: DRUG: TRX-100

A single oral dose in capsules

DRUG: Placebo

A single oral dose in capsules

BIOLOGICAL: Influenza A/France/759/2021 (H1N1) virus

A single dose of challenge agent wi...